Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retinoic acid-inducible gene-I like receptor pathway in cancer: modification and treatment. | Front Immunol | 2023 | 37662910 | PubTator, text mining | PubMed |
| Rational design of small-molecule responsive protein switches. | Protein Sci | 2023 | 37656809 | PubTator, text mining | PubMed |
| Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges. | Cell Regen | 2023 | 37656237 | PubTator, text mining | PubMed |
| Targeting Driver Oncogenes and Other Public Neoantigens Using T Cell Receptor-Based Cellular Therapy. | Annu Rev Cancer Biol | 2023 | 37655310 | PubTator, text mining | PubMed |
| Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML. | Front Immunol | 2023 | 37654497 | PubTator, text mining | PubMed |
| Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy. | Sci Transl Med | 2023 | 37651540 | PubTator, text mining | PubMed |
| CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma. | BMC Med | 2023 | 37649020 | PubTator, text mining | PubMed |
| Epitope editing enables targeted immunotherapy of acute myeloid leukaemia. | Nature | 2023 | 37648862 | PubTator, text mining | PubMed |
| Cellular Therapy in NSCLC: Between Myth and Reality. | Curr Oncol Rep | 2023 | 37646900 | PubTator, text mining | PubMed |
| CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells. | Oncoimmunology | 2023 | 37645216 | PubTator, text mining | PubMed |
| Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy. | Front Immunol | 2023 | 37638058 | PubTator, text mining | PubMed |
| CD155 and Its Receptors as Targets for Cancer Therapy. | Int J Mol Sci | 2023 | 37629138 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Ferroptosis Regulators with Regard to PD-L1 and Immune Infiltration in Low-Grade Glioma. | Int J Mol Sci | 2023 | 37629061 | PubTator, text mining | PubMed |
| Advancing Cancer Immunotherapy: From Molecular Mechanisms to Clinical Applications. | Cancers (Basel) | 2023 | 37627225 | PubTator, text mining | PubMed |
| Decoding the Complexity of Immune-Cancer Cell Interactions: Empowering the Future of Cancer Immunotherapy. | Cancers (Basel) | 2023 | 37627216 | PubTator, text mining | PubMed |
| Development of Beta-Amyloid-Specific CAR-Tregs for the Treatment of Alzheimer's Disease. | Cells | 2023 | 37626926 | PubTator, text mining | PubMed |
| Who wins the combat, CAR or TCR? | Leukemia | 2023 | 37626090 | PubTator, text mining | PubMed |
| Modulation of Radiation Doses and Chimeric Antigen Receptor T Cells: A Promising New Weapon in Solid Tumors-A Narrative Review. | J Pers Med | 2023 | 37623511 | PubTator, text mining | PubMed |
| Eradication of CD48-positive tumors by selectively enhanced YTS cells harnessing the lncRNA NeST. | iScience | 2023 | 37609636 | PubTator, text mining | PubMed |
| The multi-omics analyses of acsl1 reveal its translational significance as a tumor microenvironmental and prognostic biomarker in clear cell renal cell carcinoma. | Diagn Pathol | 2023 | 37608295 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=22